YBX1P5

Across TCGA pan-cancer cohorts, YBX1P5 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated YBX1P5 data layer.

The strongest signal is observed in testicular germ cell tumors (TGCT), where higher YBX1P5 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated YBX1P5 expression acts as an unfavorable survival marker, although some lineages such as LIHC and ACC show a favorable association.

TGCT, LUSC, and LIHC are the cancer types where YBX1P5 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
TGCT	DFS	Tertile	II,III,IV	0.363	0.954	<.001	72	view →
LUSC	OS	Tertile	IV	0.001	0.673	.014	36	view →
LIHC	OS	Tertile	All	1.000	0.449	.022	24	view →
ACC	DFS	Tertile	III,IV	0.700	0.136	.022	21	view →
UVM	DFS	Tertile	III,IV	0.079	0.674	.020	18	view →
MESO	DFS	Tertile	II,III,IV	0.201	0.518	.035	18	view →
LUAD	DFS	Tertile	IV	0.461	0.759	.011	18	view →
CESC	DFS	Tertile	III,IV	0.645	0.328	.033	12	view →
SKCM	OS	Tertile	IV	0.179	0.727	<.001	9	view →
KIRC	DFS	Quartile	IV	0.229	0.478	.047	6	view →
DLBC	DFS	Median	IV	1.000	0.415	.035	6	view →
SARC	OS	Tertile	All	0.900	0.773	.014	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

YBX1P5–TGCT (DFS)

Open the TGCT breakdown →